Skip to main content
The Markets by Proactive
Go to Proactive UK

Pharma & Biotech

Immuron looks to NASDAQ

The halt will remain in place until Thursday 1st June 2017.

Immuron (ASX:IMC) has been granted a trading halt by the ASX, with its shares placed in pre-open.

Immuron requested the halt expects to make an update regarding a proposed US NASDAQ Initial Public Offer.

The halt will remain in place until the opening of trade on Thursday 1st June 2017, or earlier if an announcement is made to the market.